| SINO BIOPHARMACEUTICAL |
| China |
| Gesundheit |
| KYG8167W1380 / A0CBDJ |
| SMZ1 (Frankfurt) |
| FRA:SMZ1, ETR:SMZ1, SMZ1:GR |
| - |
| https://www.sinobiopharm... |
|
Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The company's primary focus lies in four major categories: m..
>Volltext.. |
| 10806.19 Mio. EUR |
| 11227.77 Mio. EUR |
| 4192.73 Mio. EUR |
| 1407.52 Mio. EUR |
| 307.55 Mio. EUR |
| 0.02 EUR |
| 2202.56 Mio. EUR |
| 1555.16 Mio. EUR |
| - |
| 1.02 |
| 18.29% |
| -28.76% |
| 0.01 EUR |
| 1.82% |
| 2.22% |
| 01.09.26 - 0.0076972€ 24.06.26 - 0.0056125€ >weitere anzeigen... |
| - |
| SINO BIOPHARMACEUTICAL, SINO BIOPHARMA, SINO BIOPHARM, SINO BIO |
| 21.09.26 |
|